MetaADEDB 2.0 @ LMMD
Pyridoxal
(RADKZDMFGJYCBB-UHFFFAOYSA-N)
Structure
SMILES
O=Cc1c(CO)cnc(c1O)C
Type(s)
Experimental; Nutraceutical
Molecular Formula:
C8H9NO3
Molecular Weight:
167.162
Log P:
0.4004
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
2
TPSA:
70.42
CAS Number(s):
66-72-8
Synonym(s)
1.
Pyridoxal
External Link(s)
MeSHD011730
PubChem Compound1050
BindingDB50366979
ChEBI17310
CHEMBLCHEMBL102970
DrugBankDB00147
DrugCentral4134
KEGGcpd:C00250
ZINC120249
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainOFFSIDES
2AcneOFFSIDES
3Acute glomerulonephritisOFFSIDES
4Alanine Aminotransferase IncreasedOFFSIDES
5AnorexiaOFFSIDES
6Antinuclear antibody increasedOFFSIDES
7AnuriaOFFSIDES
8ApathyOFFSIDES
9Aspartate aminotransferase decreasedOFFSIDES
10AuraOFFSIDES
11Bilirubin conjugated increasedOFFSIDES
12Blood alkaline phosphatase increasedOFFSIDES
13Blood beta-D-glucan increasedOFFSIDES
14Blood corticotrophinOFFSIDES
15Blood creatine phosphokinase MBOFFSIDES
16Blood creatine phosphokinase increasedOFFSIDES
17Blood creatinine increasedOFFSIDES
18Blood immunoglobulin G increasedOFFSIDES
19Blood lactate dehydrogenase decreasedOFFSIDES
20Blood lactate dehydrogenase increasedOFFSIDES
21Blood potassium increasedOFFSIDES
22Blood sodiumOFFSIDES
23Blood urea increasedOFFSIDES
24Blood uric acidOFFSIDES
25BronchiectasisOFFSIDES
26CholangiolitisOFFSIDES
27Conjunctival depositOFFSIDES
28Cortisol free urine decreasedOFFSIDES
29CyanosisOFFSIDES
30Cytomegalovirus test positiveOFFSIDES
31Depressed Level of ConsciousnessOFFSIDES
32DiarrheaOFFSIDES
33Disseminated Intravascular CoagulationOFFSIDES
34Dry skinOFFSIDES
35Duodenal UlcerOFFSIDES
36Duodenal ulcer perforationOFFSIDES
37DuodenitisOFFSIDES
38DyspepsiaOFFSIDES
39EnterocolitisOFFSIDES
40Erythema MultiformeOFFSIDES
41ErythemaOFFSIDES
42Food PoisoningOFFSIDES
43Gamma-Glutamyltransferase IncreasedOFFSIDES
44Gastric mucosal lesionOFFSIDES
45Gastrointestinal motility disorderOFFSIDES
46Head titubationOFFSIDES
47Hepatitis BOFFSIDES
48Hydroxycorticosteroids urine decreasedOFFSIDES
49Intention tremorOFFSIDES
50Leukopenia neonatalOFFSIDES
51Lymphocyte count decreasedOFFSIDES
52Multi-organ disorderOFFSIDES
53Musculoskeletal stiffnessOFFSIDES
54Myoglobin blood increasedOFFSIDES
55MyringitisOFFSIDES
56Neutrophil count decreasedOFFSIDES
57Performance status decreasedOFFSIDES
58Pharyngolaryngeal PainOFFSIDES
59Pneumocystis jiroveci pneumoniaOFFSIDES
60Post procedural pneumoniaOFFSIDES
61Protein total decreasedOFFSIDES
62Pseudomonal sepsisOFFSIDES
63Psychiatric symptomOFFSIDES
64Pulmonary congestionOFFSIDES
65Pyoderma GangrenosumOFFSIDES
66Renal tubular disorderOFFSIDES
67Renal tubular necrosisOFFSIDES
68Respiratory FailureOFFSIDES
69RhabdomyolysisOFFSIDES
70RhinorrheaOFFSIDES
71Seizures7550313
10916367		CTD
72Splenic neoplasm malignancy unspecifiedOFFSIDES
73Supraventricular tachycardiaOFFSIDES
74Therapy non-responderOFFSIDES
75Transaminases increasedOFFSIDES
76Type III immune complex mediated reactionOFFSIDES
77Upper respiratory tract inflammationOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120238

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.